Zevra Therapeutics completes acquisition of Acer in a $91m deal
HQ Team November 21, 2023: Zevra Therapeutics, Inc. has finalized its acquisition of Acer Therapeutics Inc in a $91m deal. This strategic acquisition
HQ Team November 21, 2023: Zevra Therapeutics, Inc. has finalized its acquisition of Acer Therapeutics Inc in a $91m deal. This strategic acquisition
By Dr. K. Leelamoni November 21, 2023: Shawarma was a favourite dish of mine and I first came to know about it when
HQ Team November 20, 2023: A new study suggests that targeting the stellate ganglion, known as a “stellate ganglion block,” could restore smell
HQ Team November 20, 2023: Bayer, the pharmaceutical giant, has decided to halt a large late-stage trial for its experimental anticoagulant drug, asundexian.
HQ Team November 20, 2023: Micron Biomedical, a US Atlanta-based medical device company, announced a $23.6 million grant from the Bill & Melinda
HQ Team November 18, 2023: Eli Lilly, a US company that forecasts revenue of up to $33.9 billion, plans to build a $2.5
HQ Team November 18, 2023: The Food and Drug Administration (FDA) has green-lighted Astellas Pharma’s prostrate cancer drug Xtandi five weeks ahead of
HQ Team November 18, 2023: A plan to create a safe zone at Gaza’s Al-Mawasi is a “recipe for disaster” and the WHO
HQ Team November 17, 2023: Levofloxacin, an antibiotic, has emerged as a potent weapon against drug-resistant tuberculosis, offering a cost-effective solution with profound
HQ Team November 17, 2023: The number of countries battling measles outbreaks has increased to 37 in 2022 from 22 in 2021, marking